Turn Therapeutics Inc. 8-K

What Happened
On May 27, 2026, Turn Therapeutics Inc. (TTRX) issued a press release and furnished it as Exhibit 99.1 to a Current Report on Form 8‑K filed the same day. The Form 8‑K was filed under Item 7.01 (Regulation FD Disclosure) and also includes the interactive XBRL cover page as Exhibit 104. The filing’s accession number is 0001213900-26-061244.

Key Details

• Filing date: May 27, 2026.
• Item reported: 7.01 — Regulation FD Disclosure (press release furnished).
• Exhibit included: 99.1 — Press Release dated May 27, 2026.
• Administrative exhibit: 104 — Cover Page Interactive Data File (Inline XBRL).

Why It Matters
A Form 8‑K under Item 7.01 indicates Turn distributed information publicly (Regulation FD) to prevent selective disclosure. The furnished press release may contain material company news—such as updates on clinical progress, corporate developments, or financial/operational announcements—so investors should read Exhibit 99.1 directly (available on the SEC EDGAR site or the company’s investor relations page) to see if the content affects their investment decisions.